AU2015200990B2 - Optimized Fc variants - Google Patents
Optimized Fc variantsInfo
- Publication number
- AU2015200990B2 AU2015200990B2 AU2015200990A AU2015200990A AU2015200990B2 AU 2015200990 B2 AU2015200990 B2 AU 2015200990B2 AU 2015200990 A AU2015200990 A AU 2015200990A AU 2015200990 A AU2015200990 A AU 2015200990A AU 2015200990 B2 AU2015200990 B2 AU 2015200990B2
- Authority
- AU
- Australia
- Prior art keywords
- variants
- optimized
- region
- parent polypeptide
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The present invention relates to a variant of a parent polypeptide comprising an Fc region. The said variant exhibits increased binding to FcRn as compared to the parent polypeptide and comprises at least one amino acid modification in its Fc region.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2015200990A AU2015200990B2 (en) | 2009-03-20 | 2015-02-26 | Optimized Fc variants |
AU2016213792A AU2016213792B2 (en) | 2009-03-20 | 2016-08-11 | Optimized Fc variants |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09305250.4 | 2009-03-20 | ||
AU2010224800A AU2010224800B2 (en) | 2009-03-20 | 2010-03-19 | Optimized Fc variants |
AU2015200990A AU2015200990B2 (en) | 2009-03-20 | 2015-02-26 | Optimized Fc variants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010224800A Division AU2010224800B2 (en) | 2009-03-20 | 2010-03-19 | Optimized Fc variants |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2016213792A Division AU2016213792B2 (en) | 2009-03-20 | 2016-08-11 | Optimized Fc variants |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2015200990A1 AU2015200990A1 (en) | 2015-03-19 |
AU2015200990B2 true AU2015200990B2 (en) | 2016-07-21 |
Family
ID=52672553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015200990A Active AU2015200990B2 (en) | 2009-03-20 | 2015-02-26 | Optimized Fc variants |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2015200990B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3032820A1 (en) | 2016-08-02 | 2018-03-22 | Visterra, Inc. | Engineered polypeptides and uses thereof |
AU2018215673A1 (en) * | 2017-02-06 | 2019-07-25 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for augmenting antibody mediated receptor signaling |
EP4316502A2 (en) * | 2018-04-17 | 2024-02-07 | Heidelberg Biotech GmbH | Means and methods for the treatment of angiogenesis-, fibrosis- and cancer-related diseases with protein oligomers comprising nc-1-fc |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041770A1 (en) * | 2004-11-12 | 2009-02-12 | Chamberlain Aaron Keith | Fc VARIANTS WITH ALTERED BINDING TO FcRn |
-
2015
- 2015-02-26 AU AU2015200990A patent/AU2015200990B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041770A1 (en) * | 2004-11-12 | 2009-02-12 | Chamberlain Aaron Keith | Fc VARIANTS WITH ALTERED BINDING TO FcRn |
Also Published As
Publication number | Publication date |
---|---|
AU2015200990A1 (en) | 2015-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010106180A3 (en) | Optimized fc variants | |
WO2008092117A3 (en) | Immunoglobulins with modifications in the fcr binding region | |
PH12016500081B1 (en) | Immunoglobulin variants and uses thereof | |
IL250938A0 (en) | Enzymatic fusion proteins, compositions comprising the same and uses thereof | |
WO2012175751A3 (en) | Fc variants with reduced effector functions | |
WO2009100260A3 (en) | Compositions and methods comprising basic amino acid peptides and proteases | |
EP2250278A4 (en) | Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications | |
EP2504360A4 (en) | Monomeric antibody fc | |
SG159458A1 (en) | Novel immunoglobulin-binding proteins with improved specificity | |
MX2014005108A (en) | Polypeptide constructs and uses thereof. | |
MX346700B (en) | Method for improving the yield of a polypeptide. | |
AU2012257942A8 (en) | Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same | |
WO2010089411A3 (en) | Pd-1 antibodies and pd-l1 antibodies and uses thereof | |
WO2009111508A3 (en) | Metalloproteinase 9 and metalloproteinase 2 binding proteins | |
WO2009111450A3 (en) | Metalloproteinase 9 binding proteins | |
WO2010011735A3 (en) | Modified bovine g-csf polypeptides and their uses | |
MX2012004847A (en) | Gluten free structured protein product. | |
WO2010034718A8 (en) | Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation | |
WO2011028883A3 (en) | Metalloproteinase 9 and metalloproteinase 2 binding proteins | |
MX2010007716A (en) | COMBINATION OF AN ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART. | |
WO2012090150A3 (en) | New cell-penetrating peptides and uses thereof | |
WO2011152694A3 (en) | Fusion protein having factor vii activity | |
WO2009137778A3 (en) | Methods and compositions for genetically engineering clostridia species | |
WO2013071295A3 (en) | Transcript optimized expression enhancement for high-level production of proteins and protein domains | |
WO2011041499A3 (en) | Isolated rice lp2 promoter and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |